导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 52.97% | 1/76 |
| 近一周 | -5.40% | 75/86 |
| 近一月 | -6.21% | 61/85 |
| 近一季 | -12.70% | 55/85 |
| 近半年 | 31.43% | 9/78 |
| 近一年 | 66.40% | 4/74 |
| 近两年 | 140.89% | 3/70 |
| 近三年 | 126.05% | 10/62 |
| 成立以来 | 139.92% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.76% 6/76 |
66.23% 12/85 |
- - |
- - |
| 2025 | 54.26% 7/76 |
2.72% 23/74 |
14.10% 30/74 |
23.70% 19/74 |
6.41% 7/76 |
| 2024 | -0.29% 66/75 |
0.85% 58/67 |
9.63% 8/72 |
-7.60% 72/74 |
-2.39% 57/75 |
| 2023 | -2.49% 31/72 |
4.65% 23/57 |
-3.49% 40/64 |
-3.04% 21/68 |
-0.42% 51/72 |
| 2022 | -19.73% 23/46 |
-18.87% 39/43 |
8.13% 2/45 |
-16.87% 39/45 |
10.05% 12/46 |
| 2021 | -8.80% 28/43 |
6.22% 56/312 |
6.35% 116/328 |
-12.97% 241/358 |
-7.24% 37/43 |
| 2020 | 55.05% 9/41 |
-3.87% 57/280 |
25.12% 77/295 |
11.84% 35/299 |
15.27% 52/305 |
| 2019 | 32.62% 1/35 |
16.61% 37/258 |
-0.20% 180/268 |
0.92% 113/253 |
12.92% 26/266 |
| 2018 | -16.72% 15/31 |
- - |
- - |
- - |
-11.43% 125/241 |
| 2017 | 28.23% 14/30 |
- - |
- - |
- - |
- - |
| 2016 | 2.29% 14/31 |
- - |
- - |
- - |
- - |
| 2015 | -19.71% 21/30 |
- - |
- - |
- - |
- - |
| 2014 | 1.47% 54/99 |
- - |
- - |
- - |
- - |
| 2013 | -3.32% 50/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 诺安油气能源 | 1.4840 | 19.20% |
| 平安港股医疗优选股票(QDII)A | 0.9420 | 17.84% |
| 平安港股医疗优选股票(QDII)C | 0.9385 | 17.67% |
| 创金合信全球医药生物股票发起(QDII)A | 1.5257 | 7.60% |
| 创金合信全球医药生物股票发起(QDII)C | 1.5054 | 7.47% |
| 长城港股价值优选股票(QDII)C | 0.9674 | 1.73% |
| 华宝海外科技股票(QDII-LOF)A | 2.3545 | 0.22% |
| 长城港股价值优选股票(QDII)A | 0.9692 | 0.22% |
| 宏利印度股票(QDII) | 1.3125 | 0.05% |
| 宏利印度股票(QDII)C | 1.3092 | -0.03% |
| 国富亚洲机会股票(QDII)A VS. 华宝海外科技股票(QDII(501312) |